GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » 3-Year EPS without NRI Growth Rate

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) 3-Year EPS without NRI Growth Rate : 9.40% (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co 3-Year EPS without NRI Growth Rate?

Zhejiang Ausun Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2025 was ¥0.15.

During the past 12 months, Zhejiang Ausun Pharmaceutical Co's average EPS without NRI Growth Rate was -24.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 9.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 30.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Zhejiang Ausun Pharmaceutical Co was 77.00% per year. The lowest was -29.80% per year. And the median was 11.60% per year.


Competitive Comparison of Zhejiang Ausun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Ausun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate falls into.


;
;

Zhejiang Ausun Pharmaceutical Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Zhejiang Ausun Pharmaceutical Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Ausun Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
Executives
Zheng Zhi Guo Directors, senior managers
Zhang Hua Dong Directors, senior managers
Liu Bing Director

Zhejiang Ausun Pharmaceutical Co Headlines

No Headlines